Pages that link to "Q50991247"
Jump to navigation
Jump to search
The following pages link to Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity (Q50991247):
Displaying 8 items.
- Cardiovascular complications of diabetic kidney disease. (Q33711038) (← links)
- Clinical pharmacokinetics and pharmacodynamics of clopidogrel (Q38307535) (← links)
- Oral P2Y12 Receptor Inhibitors in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions: Current Knowledge and Future Directions (Q38802950) (← links)
- Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS) (Q39205827) (← links)
- Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity (Q42245258) (← links)
- Role of P2Y12 Receptor in Thrombosis (Q51507695) (← links)
- Platelet function testing in contemporary clinical and interventional practice (Q51746988) (← links)
- Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial (Q64103474) (← links)